25 XP   0   0   10

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Nanjing King-friend Biochemical Pharmaceutical Co Ltd together

PenkeI guess you are interested in Nanjing King-friend Biochemical Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nanjing King-friend Biochemical Pharmaceutical Co Ltd

I send you an email if I find something interesting about Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Quick analysis of Nanjing King-friend Biochemical Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Nanjing King-friend Biochemical Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.08
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.81
Expected worth in 1 year
¥5.70
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.45
Return On Investment
18.5%

For what price can you sell your share?

Current Price per Share
¥13.24
Expected price per share
¥10.75 - ¥14.88
How sure are you?
50%

1. Valuation of Nanjing King-friend Biochemical Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥13.24

Intrinsic Value Per Share

¥0.68 - ¥9.14

Total Value Per Share

¥4.49 - ¥12.95

2. Growth of Nanjing King-friend Biochemical Pharmaceutical Co Ltd (5 min.)




Is Nanjing King-friend Biochemical Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$851m$745.5m$105.4m12.4%

How much money is Nanjing King-friend Biochemical Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$150.5m$146.1m$4.3m2.9%
Net Profit Margin29.4%28.7%--

How much money comes from the company's main activities?

3. Financial Health of Nanjing King-friend Biochemical Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Nanjing King-friend Biochemical Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Nanjing King-friend Biochemical Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Nanjing King-friend Biochemical Pharmaceutical Co Ltd is ¥13.24. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nanjing King-friend Biochemical Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.81. Based on the TTM, the Book Value Change Per Share is ¥0.47 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.14 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.090.7%0.090.7%0.090.7%0.070.5%0.040.3%
Usd Book Value Change Per Share0.070.5%0.070.5%0.141.1%0.070.5%0.060.4%
Usd Dividend Per Share0.020.1%0.020.1%0.020.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.080.6%0.080.6%0.161.2%0.080.6%0.070.5%
Usd Price Per Share2.49-2.49-5.80-4.29-2.82-
Price to Earnings Ratio26.74-26.74-64.10-68.72-54.32-
Price-to-Total Gains Ratio29.48-29.48-36.70-57.93-57.65-
Price to Book Ratio4.73-4.73-12.57-13.46-9.95-
Price-to-Total Gains Ratio29.48-29.48-36.70-57.93-57.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.82712
Number of shares547
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.070.07
Usd Total Gains Per Share0.080.08
Gains per Quarter (547 shares)46.2046.38
Gains per Year (547 shares)184.79185.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14214217532154176
28528536064307362
312742754596461548
4169570730127615734
5212712915159768920
625485511001919221106
7296997128522310761292
83391140147025512291478
93811282165528713831664
104231425184031915361850

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.01.088.9%8.00.01.088.9%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%

Fundamentals of Nanjing King-friend Biochemical Pharmaceutical Co Ltd

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tigecycline, glycopyrrolate, melphalan, daptomycin, decitabine, haloperidol decanoate, carmustine, bivalirudin, dexmedetomidine, and neostigmine methylsulfate injections. It also offers isosulfan blue, succinylcholine chloride, furosemide, regadenoson, voriconazole, ganirelix acetate, eptifibatide, enoxaparin sodium, mitomycin, vancomycin, micafungin sodium, docetaxel, nelarabine, pemetrexed, rocuronium bromide, zoledronic acid, thiamine, fluorouracil, perixafor, thiotepa, pantoprazole sodium, glatiramer acetate, and bupivacaine hydrochloride injections. The company was founded in 2000 and is based in Nanjing, China.

Fundamental data was last updated by Penke on 2024-04-18 13:45:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nanjing King-friend Biochemical Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 29.4% means that ¥0.29 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 29.4%. The company is making a huge profit. +2
  • The TTM is 29.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ29.4%TTM29.4%0.0%
TTM29.4%YOY28.7%+0.6%
TTM29.4%5Y27.0%+2.3%
5Y27.0%10Y23.1%+4.0%
1.1.2. Return on Assets

Shows how efficient Nanjing King-friend Biochemical Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.9% Return on Assets means that Nanjing King-friend Biochemical Pharmaceutical Co Ltd generated ¥0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 10.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.9%TTM10.9%0.0%
TTM10.9%YOY12.9%-2.0%
TTM10.9%5Y11.7%-0.8%
5Y11.7%10Y9.7%+2.0%
1.1.3. Return on Equity

Shows how efficient Nanjing King-friend Biochemical Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 17.7% Return on Equity means Nanjing King-friend Biochemical Pharmaceutical Co Ltd generated ¥0.18 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 17.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.7%TTM17.7%0.0%
TTM17.7%YOY19.7%-2.0%
TTM17.7%5Y19.4%-1.7%
5Y19.4%10Y14.6%+4.7%

1.2. Operating Efficiency of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nanjing King-friend Biochemical Pharmaceutical Co Ltd is operating .

  • Measures how much profit Nanjing King-friend Biochemical Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY33.4%-33.4%
TTM-5Y23.8%-23.8%
5Y23.8%10Y22.6%+1.2%
1.2.2. Operating Ratio

Measures how efficient Nanjing King-friend Biochemical Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.20 means that the operating costs are ¥1.20 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 1.198. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.198. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.198TTM1.1980.000
TTM1.198YOY1.096+0.102
TTM1.1985Y1.165+0.033
5Y1.16510Y1.095+0.070

1.3. Liquidity of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nanjing King-friend Biochemical Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.07 means the company has ¥3.07 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 3.067. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.067. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.067TTM3.0670.000
TTM3.067YOY3.058+0.009
TTM3.0675Y2.728+0.338
5Y2.72810Y2.595+0.133
1.3.2. Quick Ratio

Measures if Nanjing King-friend Biochemical Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.35 means the company can pay off ¥0.35 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 0.353. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.353. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.353TTM0.3530.000
TTM0.353YOY0.484-0.132
TTM0.3535Y0.388-0.036
5Y0.38810Y0.648-0.260

1.4. Solvency of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nanjing King-friend Biochemical Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.38 means that Nanjing King-friend Biochemical Pharmaceutical Co Ltd assets are financed with 38.4% credit (debt) and the remaining percentage (100% - 38.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 0.384. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.384. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.384TTM0.3840.000
TTM0.384YOY0.342+0.041
TTM0.3845Y0.388-0.004
5Y0.38810Y0.311+0.076
1.4.2. Debt to Equity Ratio

Measures if Nanjing King-friend Biochemical Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 62.3% means that company has ¥0.62 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The MRQ is 0.623. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.623. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.623TTM0.6230.000
TTM0.623YOY0.523+0.100
TTM0.6235Y0.664-0.041
5Y0.66410Y0.497+0.167

2. Market Valuation of Nanjing King-friend Biochemical Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Nanjing King-friend Biochemical Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 26.74 means the investor is paying ¥26.74 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The EOD is 19.627. Based on the earnings, the company is fair priced.
  • The MRQ is 26.743. Based on the earnings, the company is overpriced. -1
  • The TTM is 26.743. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD19.627MRQ26.743-7.116
MRQ26.743TTM26.7430.000
TTM26.743YOY64.099-37.356
TTM26.7435Y68.723-41.980
5Y68.72310Y54.317+14.406
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The EOD is 170.779. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 232.693. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 232.693. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD170.779MRQ232.693-61.914
MRQ232.693TTM232.6930.000
TTM232.693YOY279.567-46.874
TTM232.6935Y-222.373+455.065
5Y-222.37310Y-139.601-82.771
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nanjing King-friend Biochemical Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Nanjing King-friend Biochemical Pharmaceutical Co Ltd:

  • The EOD is 3.472. Based on the equity, the company is fair priced.
  • The MRQ is 4.730. Based on the equity, the company is fair priced.
  • The TTM is 4.730. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.472MRQ4.730-1.259
MRQ4.730TTM4.7300.000
TTM4.730YOY12.568-7.837
TTM4.7305Y13.464-8.734
5Y13.46410Y9.951+3.513
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nanjing King-friend Biochemical Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4720.4720%1.026-54%0.509-7%0.424+11%
Book Value Per Share--3.8143.8140%3.342+14%2.566+49%1.803+112%
Current Ratio--3.0673.0670%3.058+0%2.728+12%2.595+18%
Debt To Asset Ratio--0.3840.3840%0.342+12%0.388-1%0.311+23%
Debt To Equity Ratio--0.6230.6230%0.523+19%0.664-6%0.497+25%
Dividend Per Share--0.1400.1400%0.119+18%0.106+33%0.071+97%
Eps--0.6750.6750%0.655+3%0.493+37%0.319+111%
Free Cash Flow Per Share--0.0780.0780%0.150-48%-0.182+334%-0.129+267%
Free Cash Flow To Equity Per Share--0.0780.0780%-0.414+634%0.060+29%0.047+66%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.778+29%
Intrinsic Value_10Y_max--9.139--------
Intrinsic Value_10Y_min--0.679--------
Intrinsic Value_1Y_max--0.118--------
Intrinsic Value_1Y_min---0.120--------
Intrinsic Value_3Y_max--0.963--------
Intrinsic Value_3Y_min---0.200--------
Intrinsic Value_5Y_max--2.541--------
Intrinsic Value_5Y_min---0.103--------
Market Cap21404445788.160-36%29172030763.04029172030763.0400%67899299328.000-57%50253545778.991-42%32989510697.587-12%
Net Profit Margin--0.2940.2940%0.287+2%0.270+9%0.231+27%
Operating Margin----0%0.334-100%0.238-100%0.226-100%
Operating Ratio--1.1981.1980%1.096+9%1.165+3%1.095+9%
Pb Ratio3.472-36%4.7304.7300%12.568-62%13.464-65%9.951-52%
Pe Ratio19.627-36%26.74326.7430%64.099-58%68.723-61%54.317-51%
Price Per Share13.240-36%18.04018.0400%42.000-57%31.084-42%20.406-12%
Price To Free Cash Flow Ratio170.779-36%232.693232.6930%279.567-17%-222.373+196%-139.601+160%
Price To Total Gains Ratio21.634-36%29.47729.4770%36.703-20%57.927-49%57.654-49%
Quick Ratio--0.3530.3530%0.484-27%0.388-9%0.648-46%
Return On Assets--0.1090.1090%0.129-15%0.117-7%0.097+13%
Return On Equity--0.1770.1770%0.197-10%0.194-9%0.146+21%
Total Gains Per Share--0.6120.6120%1.144-47%0.6140%0.495+24%
Usd Book Value--851069462.248851069462.2480%745580471.423+14%572415568.718+49%402210199.234+112%
Usd Book Value Change Per Share--0.0650.0650%0.142-54%0.070-7%0.058+11%
Usd Book Value Per Share--0.5260.5260%0.461+14%0.354+49%0.249+112%
Usd Dividend Per Share--0.0190.0190%0.016+18%0.015+33%0.010+97%
Usd Eps--0.0930.0930%0.090+3%0.068+37%0.044+111%
Usd Free Cash Flow--17300672.02017300672.0200%33516523.944-48%-40548558.460+334%-28863683.841+267%
Usd Free Cash Flow Per Share--0.0110.0110%0.021-48%-0.025+334%-0.018+267%
Usd Free Cash Flow To Equity Per Share--0.0110.0110%-0.057+634%0.008+29%0.006+66%
Usd Market Cap2953813518.766-36%4025740245.3004025740245.3000%9370103307.264-57%6934989317.501-42%4552552476.267-12%
Usd Price Per Share1.827-36%2.4902.4900%5.796-57%4.290-42%2.816-12%
Usd Profit--150534982.140150534982.1400%146182479.697+3%110006961.144+37%69877395.737+115%
Usd Revenue--512355422.790512355422.7900%508763627.313+1%399766522.936+28%261342028.125+96%
Usd Total Gains Per Share--0.0840.0840%0.158-47%0.0850%0.068+24%
 EOD+4 -4MRQTTM+0 -0YOY+17 -185Y+21 -1410Y+26 -10

3.2. Fundamental Score

Let's check the fundamental score of Nanjing King-friend Biochemical Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.627
Price to Book Ratio (EOD)Between0-13.472
Net Profit Margin (MRQ)Greater than00.294
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.353
Current Ratio (MRQ)Greater than13.067
Debt to Asset Ratio (MRQ)Less than10.384
Debt to Equity Ratio (MRQ)Less than10.623
Return on Equity (MRQ)Greater than0.150.177
Return on Assets (MRQ)Greater than0.050.109
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Nanjing King-friend Biochemical Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.979
Ma 20Greater thanMa 5012.430
Ma 50Greater thanMa 10012.752
Ma 100Greater thanMa 20013.647
OpenGreater thanClose13.180
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets10,010,103
Total Liabilities3,842,933
Total Stockholder Equity6,170,641
 As reported
Total Liabilities 3,842,933
Total Stockholder Equity+ 6,170,641
Total Assets = 10,010,103

Assets

Total Assets10,010,103
Total Current Assets8,294,065
Long-term Assets1,716,038
Total Current Assets
Cash And Cash Equivalents 1,388,512
Short-term Investments 1,300
Net Receivables 952,099
Inventory 5,615,601
Other Current Assets 47,540
Total Current Assets  (as reported)8,294,065
Total Current Assets  (calculated)8,005,053
+/- 289,012
Long-term Assets
Property Plant Equipment 1,197,598
Goodwill 125,478
Intangible Assets 212,195
Long-term Assets Other 16,305
Long-term Assets  (as reported)1,716,038
Long-term Assets  (calculated)1,551,576
+/- 164,462

Liabilities & Shareholders' Equity

Total Current Liabilities2,704,654
Long-term Liabilities1,138,279
Total Stockholder Equity6,170,641
Total Current Liabilities
Short Long Term Debt 1,956,863
Accounts payable 505,120
Other Current Liabilities 6,732
Total Current Liabilities  (as reported)2,704,654
Total Current Liabilities  (calculated)2,468,715
+/- 235,939
Long-term Liabilities
Long term Debt 991,195
Capital Lease Obligations Min Short Term Debt15,940
Long-term Liabilities  (as reported)1,138,279
Long-term Liabilities  (calculated)1,007,135
+/- 131,144
Total Stockholder Equity
Retained Earnings 3,438,074
Total Stockholder Equity (as reported)6,170,641
Total Stockholder Equity (calculated)3,438,074
+/- 2,732,568
Other
Capital Stock1,617,075
Common Stock Shares Outstanding 1,617,075
Net Debt 1,559,546
Net Invested Capital 9,118,699
Net Working Capital 5,589,411
Property Plant and Equipment Gross 1,900,872



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
1,540,113
1,297,396
1,522,703
2,694,760
3,402,323
5,078,419
7,720,360
8,216,888
10,010,103
10,010,1038,216,8887,720,3605,078,4193,402,3232,694,7601,522,7031,297,3961,540,113
   > Total Current Assets 
0
0
1,053,393
2,191,875
2,838,015
4,288,776
6,768,091
6,929,830
8,294,065
8,294,0656,929,8306,768,0914,288,7762,838,0152,191,8751,053,39300
       Cash And Cash Equivalents 
594,350
432,420
265,693
73,126
434,805
364,162
493,553
658,553
1,388,512
1,388,512658,553493,553364,162434,80573,126265,693432,420594,350
       Short-term Investments 
228,537
180,000
0
520,000
0
56,636
845,794
259,799
1,300
1,300259,799845,79456,6360520,0000180,000228,537
       Net Receivables 
68,396
66,182
103,712
291,855
256,654
459,344
783,312
837,304
952,099
952,099837,304783,312459,344256,654291,855103,71266,18268,396
       Other Current Assets 
2,073
5,382
11,855
12,975
195,051
119,715
65,899
43,617
47,540
47,54043,61765,899119,715195,05112,97511,8555,3822,073
   > Long-term Assets 
0
0
469,310
502,885
564,309
789,643
952,269
1,287,058
1,716,038
1,716,0381,287,058952,269789,643564,309502,885469,31000
       Property Plant Equipment 
271,795
302,742
398,849
402,658
471,228
481,594
532,831
827,420
1,197,598
1,197,598827,420532,831481,594471,228402,658398,849302,742271,795
       Goodwill 
0
0
0
0
0
125,687
117,556
114,868
125,478
125,478114,868117,556125,68700000
       Intangible Assets 
13,652
13,319
45,460
44,671
73,643
125,032
159,124
199,931
212,195
212,195199,931159,124125,03273,64344,67145,46013,31913,652
       Long-term Assets Other 
0
0
15,667
45,835
8,946
41,267
116,082
82,343
16,305
16,30582,343116,08241,2678,94645,83515,66700
> Total Liabilities 
508,257
204,720
208,094
642,496
981,211
2,074,325
3,975,800
2,814,131
3,842,933
3,842,9332,814,1313,975,8002,074,325981,211642,496208,094204,720508,257
   > Total Current Liabilities 
486,254
183,082
172,582
606,631
947,411
2,033,310
2,806,063
2,266,456
2,704,654
2,704,6542,266,4562,806,0632,033,310947,411606,631172,582183,082486,254
       Short-term Debt 
0
0
119,964
322,876
319,946
0
0
0
0
0000319,946322,876119,96400
       Short Long Term Debt 
0
0
119,964
322,876
319,946
1,368,366
2,132,430
1,570,663
1,956,863
1,956,8631,570,6632,132,4301,368,366319,946322,876119,96400
       Accounts payable 
40,438
27,106
14,248
209,632
512,444
487,672
502,221
456,586
505,120
505,120456,586502,221487,672512,444209,63214,24827,10640,438
       Other Current Liabilities 
53,017
54,921
26,620
56,379
91,658
127,519
124,151
174,644
6,732
6,732174,644124,151127,51991,65856,37926,62054,92153,017
   > Long-term Liabilities 
0
0
35,511
35,866
33,800
41,015
1,169,737
547,675
1,138,279
1,138,279547,6751,169,73741,01533,80035,86635,51100
       Capital Lease Obligations Min Short Term Debt
0
0
-119,964
-322,876
-319,946
0
0
0
15,940
15,940000-319,946-322,876-119,96400
       Deferred Long Term Liability 
0
6,384
6,210
4,633
27,669
49,480
55,520
77,654
0
077,65455,52049,48027,6694,6336,2106,3840
> Total Stockholder Equity
1,031,855
1,092,676
1,314,609
2,052,264
2,421,113
2,966,493
3,722,439
5,377,921
6,170,641
6,170,6415,377,9213,722,4392,966,4932,421,1132,052,2641,314,6091,092,6761,031,855
   Common Stock
360,000
360,000
360,000
423,500
552,426
718,474
934,161
1,243,600
0
01,243,600934,161718,474552,426423,500360,000360,000360,000
   Retained Earnings 
415,492
476,046
697,285
1,011,508
1,372,532
1,894,593
2,485,140
3,123,215
3,438,074
3,438,0743,123,2152,485,1401,894,5931,372,5321,011,508697,285476,046415,492
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
116
810
497
3,702
13,824
159,792
70,449
0
070,449159,79213,8243,7024978101160



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,003,640
Cost of Revenue-2,001,792
Gross Profit2,001,8482,001,848
 
Operating Income (+$)
Gross Profit2,001,848
Operating Expense-2,934,649
Operating Income1,068,991-932,801
 
Operating Expense (+$)
Research Development314,945
Selling General Administrative475,361
Selling And Marketing Expenses-
Operating Expense2,934,649790,306
 
Net Interest Income (+$)
Interest Income15,920
Interest Expense-76,383
Other Finance Cost-74,626
Net Interest Income-135,089
 
Pretax Income (+$)
Operating Income1,068,991
Net Interest Income-135,089
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,092,4061,068,991
EBIT - interestExpense = -76,383
1,023,093
1,099,476
Interest Expense76,383
Earnings Before Interest and Taxes (EBIT)-1,168,789
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,092,406
Tax Provision-71,403
Net Income From Continuing Ops1,021,0031,021,003
Net Income1,023,093
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-135,089
 

Technical Analysis of Nanjing King-friend Biochemical Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The general trend of Nanjing King-friend Biochemical Pharmaceutical Co Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nanjing King-friend Biochemical Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 13.29 < 14.44 < 14.88.

The bearish price targets are: 11.99 > 10.75.

Tweet this
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current macd is 0.16110579.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nanjing King-friend Biochemical Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Nanjing King-friend Biochemical Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Nanjing King-friend Biochemical Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current adx is 16.97.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nanjing King-friend Biochemical Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current sar is 12.02.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current rsi is 60.98. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nanjing King-friend Biochemical Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current cci is 109.40.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current cmo is 33.52.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current willr is -13.01369863.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Williams %R ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current atr is 0.50381573.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current obv is 125,855,317.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd. The current mfi is 72.36.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartNanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nanjing King-friend Biochemical Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.979
Ma 20Greater thanMa 5012.430
Ma 50Greater thanMa 10012.752
Ma 100Greater thanMa 20013.647
OpenGreater thanClose13.180
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nanjing King-friend Biochemical Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Nanjing King-friend Biochemical Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nanjing King-friend Biochemical Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nanjing King-friend Biochemical Pharmaceutical Co Ltd

I send you an email if I find something interesting about Nanjing King-friend Biochemical Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Receive notifications about Nanjing King-friend Biochemical Pharmaceutical Co Ltd in your mailbox!